Kimberly J. Popovits, Director at Talis Biomedical Corp (TLIS), bought 97,357 shares at $16.00 ($85K) on 2021-02-17, disclosed to the SEC on 2021-02-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 92,057 | $0 | 0.0% |
| 2 | $16.00 | 5,300 | $85K | 100.0% |
| Total | $0.87 avg | 97,357 | $85K | 100% |
| Filing → |
| GHDX | SELL | 2019-08-14 | $7.4M | — | Filing → |
| GHDX | SELL | 2019-08-12 | $5.5M | — | Filing → |
| GHDX | SELL | 2019-04-10 | $1.3M | — | Filing → |